Beyond Meat Stock Drops After Another Weak Quarter
Beyond Meat missed earnings, stock fell 9%. Sales weak, losses high, but costs improved. Demand for plant meat still low.
Already have an account? Sign in.
Beyond Meat missed earnings, stock fell 9%. Sales weak, losses high, but costs improved. Demand for plant meat still low.
Abivax shares fell after Scorpion Capital claimed its ulcerative colitis drug is toxic. The company rejected the report and reaffirmed its Phase 3 data.
CrowdStrike is reportedly in talks to acquire Zscaler in a potential $265 billion cybersecurity deal, one of the largest in the sector.
Canadian Solar shares fell sharply after a report that the solar firm and its Recurrent Energy unit are considering asset sales and a possible Chapter 11 filing.
Be the first to know when deals break, stocks move, or biotech headlines hit.